| molecular function |
|---|
| | GO:0030306 | | ADP-ribosylation factor binding | | Interacting selectively and non-covalently with ARF, ADP-ribosylation factor, a small monomeric cytosolic GTPase that, when bound to GTP, binds to the membranes of cells. |
| | GO:0001540 | | amyloid-beta binding | | Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor. |
| | GO:0030169 | | low-density lipoprotein particle binding | | Interacting selectively and non-covalently with a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0004888 | | transmembrane signaling receptor activity | | Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction. |
| biological process |
|---|
| | GO:0008203 | | cholesterol metabolic process | | The chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. It is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues. |
| | GO:0006897 | | endocytosis | | A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle. |
| | GO:0006629 | | lipid metabolic process | | The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids. |
| | GO:0006869 | | lipid transport | | The directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. |
| | GO:0043407 | | negative regulation of MAP kinase activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity. |
| | GO:1902430 | | negative regulation of amyloid-beta formation | | Any process that stops, prevents or reduces the frequency, rate or extent of amyloid-beta formation. |
| | GO:1902960 | | negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process | | Any process that stops, prevents or reduces the frequency, rate or extent of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process. |
| | GO:1902963 | | negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process | | Any process that stops, prevents or reduces the frequency, rate or extent of metalloendopeptidase activity involved in amyloid precursor protein catabolic process. |
| | GO:1902997 | | negative regulation of neurofibrillary tangle assembly | | Any process that stops, prevents or reduces the frequency, rate or extent of neurofibrillary tangle assembly. |
| | GO:0050768 | | negative regulation of neurogenesis | | Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the origin and formation of neurons. |
| | GO:1901215 | | negative regulation of neuron death | | Any process that stops, prevents or reduces the frequency, rate or extent of neuron death. |
| | GO:0032091 | | negative regulation of protein binding | | Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding. |
| | GO:0032460 | | negative regulation of protein oligomerization | | Any process that stops, prevents, or reduces the frequency, rate or extent of protein oligomerization. |
| | GO:1902948 | | negative regulation of tau-protein kinase activity | | Any process that stops, prevents or reduces the frequency, rate or extent of tau-protein kinase activity. |
| | GO:1902953 | | positive regulation of ER to Golgi vesicle-mediated transport | | Any process that activates or increases the frequency, rate or extent of ER to Golgi vesicle-mediated transport. |
| | GO:1902771 | | positive regulation of choline O-acetyltransferase activity | | Any process that activates or increases the frequency, rate or extent of choline O-acetyltransferase activity. |
| | GO:1902955 | | positive regulation of early endosome to recycling endosome transport | | Any process that activates or increases the frequency, rate or extent of early endosome to recycling endosome transport. |
| | GO:2001137 | | positive regulation of endocytic recycling | | Any process that activates or increases the frequency, rate or extent of endocytic recycling. |
| | GO:0045732 | | positive regulation of protein catabolic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds. |
| | GO:0070863 | | positive regulation of protein exit from endoplasmic reticulum | | Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the endoplasmic reticulum. |
| | GO:1902966 | | positive regulation of protein localization to early endosome | | Any process that activates or increases the frequency, rate or extent of protein localization to early endosome. |
| | GO:0006892 | | post-Golgi vesicle-mediated transport | | The directed movement of substances from the Golgi to other parts of the cell, including organelles and the plasma membrane, mediated by small transport vesicles. |
| | GO:0051604 | | protein maturation | | Any process leading to the attainment of the full functional capacity of a protein. |
| | GO:0045053 | | protein retention in Golgi apparatus | | The retention of proteins within the Golgi apparatus. Golgi-localized carbohydrate-modifying enzymes have a short N-terminal domain that faces the cytosol, a single transmembrane alpha helix, and a large C-terminal domain that faces the Golgi lumen and that contains the catalytic site. How the membrane-spanning alpha helix in a Golgi enzyme causes its localization and prevents its movement to the plasma membrane is not known. |
| | GO:0006605 | | protein targeting | | The process of targeting specific proteins to particular regions of the cell, typically membrane-bounded subcellular organelles. Usually requires an organelle specific protein sequence motif. |
| | GO:0000042 | | protein targeting to Golgi | | The process of directing proteins towards the Golgi; usually uses signals contained within the protein. |
| | GO:0006622 | | protein targeting to lysosome | | The process of directing proteins towards the lysosome using signals contained within the protein. |
| | GO:0006898 | | receptor-mediated endocytosis | | An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles. |
| | GO:0014910 | | regulation of smooth muscle cell migration | | Any process that modulates the frequency, rate or extent of smooth muscle cell migration. |
| | GO:0007165 | | signal transduction | | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
| | GO:0008202 | | steroid metabolic process | | The chemical reactions and pathways involving steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus. |
| | GO:0006810 | | transport | | The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter, pore or motor protein. |
| cellular component |
|---|
| | GO:0005794 | | Golgi apparatus | | A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions. |
| | GO:0031985 | | Golgi cisterna | | Any of the thin, flattened membrane-bounded compartments that form the central portion of the Golgi complex. |
| | GO:0005769 | | early endosome | | A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways. |
| | GO:0005783 | | endoplasmic reticulum | | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
| | GO:0005768 | | endosome | | A vacuole to which materials ingested by endocytosis are delivered. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| | GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0005887 | | integral component of plasma membrane | | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0034362 | | low-density lipoprotein particle | | A lipoprotein particle, rich in cholesterol esters and low in triglycerides that is typically composed of APOB100 and APOE and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm. LDL particles are formed from VLDL particles (via IDL) by the loss of triglyceride and gain of cholesterol ester. They transport endogenous cholesterol (and to some extent triglycerides) from peripheral tissues back to the liver. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0005641 | | nuclear envelope lumen | | The region between the two lipid bilayers of the nuclear envelope; 20-40 nm wide. |
| | GO:0055037 | | recycling endosome | | An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane. |
| | GO:0005802 | | trans-Golgi network | | The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination. |
Description
